A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
Clinical trial NCT03101280 · COMPLETED
Trial details
- NCT number
- NCT03101280
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2020-08-11
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.